Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Depreciation & Amortization (CF) (2021 - 2026)

HeartSciences' Depreciation & Amortization (CF) history spans 6 years, with the latest figure at $6916.0 for Q1 2026.

  • For Q1 2026, Depreciation & Amortization (CF) rose 15.13% year-over-year to $6916.0; the TTM value through Jan 2026 reached $28546.0, down 27.34%, while the annual FY2025 figure was $37599.0, 34.8% up from the prior year.
  • Depreciation & Amortization (CF) reached $6916.0 in Q1 2026 per HSCS's latest filing, down from $7006.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $12215.0 in Q4 2024 to a low of $3717.0 in Q1 2024.
  • Average Depreciation & Amortization (CF) over 5 years is $7437.1, with a median of $6916.0 recorded in 2026.
  • The largest YoY upside for Depreciation & Amortization (CF) was 61.68% in 2024 against a maximum downside of 45.86% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $6813.0 in 2022, then rose by 12.08% to $7636.0 in 2023, then soared by 59.97% to $12215.0 in 2024, then crashed by 42.64% to $7006.0 in 2025, then fell by 1.28% to $6916.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Depreciation & Amortization (CF) are $6916.0 (Q1 2026), $7006.0 (Q4 2025), and $7111.0 (Q3 2025).